Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$127.77

1.77 (1.40%)

20:01
07/12/18
07/12
20:01
07/12/18
20:01

Johnson & Johnson responds to $4.69B verdict against company

The company states: "Johnson & Johnson is deeply disappointed in the verdict, which was the product of a fundamentally unfair process that allowed plaintiffs to present a group of 22 women, most of whom had no connection to Missouri, in a single case all alleging that they developed ovarian cancer. The result of the verdict, which awarded the exact same amounts to all plaintiffs irrespective of their individual facts, and differences in applicable law, reflects that the evidence in the case was simply overwhelmed by the prejudice of this type of proceeding. Johnson & Johnson remains confident that its products do not contain asbestos and do not cause ovarian cancer and intends to pursue all available appellate remedies. Every verdict against Johnson & Johnson in this court that has gone through the appeals process has been reversed and the multiple errors present in this trial were worse than those in the prior trials which have been reversed."

  • 17

    Jul

JNJ Johnson & Johnson
$127.77

1.77 (1.40%)

07/06/18
RBCM
07/06/18
NO CHANGE
Target $143
RBCM
Outperform
Johnson & Johnson price target lowered to $143 from $155 at RBC Capital
RBC Capital analyst Glenn Novarro lowered his price target on Johnson & Johnson to $143 ahead of its Q2 results, saying the trends in the U.S. prescription drug market suggest that any upside in the company's Pharmaceutical segment is unlikely. Novarro expects the management to affirm its FY18 guidance for operational growth and earnings, but warns that the revenue guidance may see a downgrade due to the recent USD strength. The analyst also lowered his FY18 revenue projections to $81.1B from $81.3B and FY19 forecast to $80.6B from $83.0B.
07/11/18
WELS
07/11/18
NO CHANGE
WELS
Drug stocks may not react favorably to Pfizer price rollback, Trump tweets, says Wells Fargo
Wells Fargo analyst David Maris notes that there was widespread media coverage of drug price increases taken recently by several large cap drug companies, with President Trump criticizing Pfizer (PFE) for taking these price increases. On Tuesday, Pfizer confirmed it was rolling back its July drug price increases following a conversation with President Trump, he adds. Maris believes that drug stocks will not react favorably to this news, given the chilling effect this will likely have on others looking to take price increases. Nonetheless, the analyst points out that the price increases taken in July are only a small number of increases taken over the past year or several years, so the impact of the rollback to the healthcare system is insignificant in the big picture. Other publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY) and Sanofi (SNY).
07/12/18
GSCO
07/12/18
UPGRADE
GSCO
Neutral
Johnson & Johnson upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Jami Rubin upgraded Johnson & Johnson (JNJ) to Neutral with an unchanged price target of $134. The shares closed yesterday down $1.11 to $126.24. The stock is down 10% year-to-date and 15% from its recent all-time high of $148, Rubin tells investors in a research note. She notes J&J is trading in line with the large cap Pharmaceuticals group at 15 times 2019 estimates. The company's non-operational earnings revisions are now better understood by investors at current share levels, Rubin contends. The analyst this morning also downgraded Perrigo (PRGO) to Sell from Neutral.
07/12/18
07/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) upgraded to Neutral from Sell at Goldman Sachs with analyst Jami Rubin saying the stock is down 10% year-to-date and 15% from its recent all-time high of $148. 2. Hallmark Financial (HALL) upgraded to Outperform from Market Perform at Raymond James. 3. Transocean (RIG), Ensco (ESV), and Rowan Companies (RDC) were upgraded to Buy from Hold at Tudor Pickering. 4. Precision Drilling (PDS) and Nabors Industries (NBR) were upgraded to Overweight from Equal Weight at Morgan Stanley. 5. CA Technologies (CA) upgraded to Market Perform from Underperform at Wells Fargo and Bernstein. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MCD

McDonald's

$175.81

9.28 (5.57%)

11:37
10/23/18
10/23
11:37
10/23/18
11:37
Hot Stocks
Breaking Hot Stocks news story on McDonald's »

McDonald's says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

11:37
10/23/18
10/23
11:37
10/23/18
11:37
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

11:37
10/23/18
10/23
11:37
10/23/18
11:37
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

FSNN

Fusion

$2.37

-0.035 (-1.46%)

11:37
10/23/18
10/23
11:37
10/23/18
11:37
Conference/Events
Fusion management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 15

    Nov

CAT

Caterpillar

$119.44

-9.2 (-7.15%)

11:35
10/23/18
10/23
11:35
10/23/18
11:35
Hot Stocks
Caterpillar will have 'stiff tailwind next year' »

Caterpillar CEO Jim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

STX

Seagate

$42.62

-1 (-2.29%)

11:35
10/23/18
10/23
11:35
10/23/18
11:35
Options
Seagate put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 02

    Nov

HSBC

HSBC

$39.61

-0.745 (-1.85%)

11:32
10/23/18
10/23
11:32
10/23/18
11:32
Downgrade
HSBC rating change  »

HSBC downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$118.96

-9.68 (-7.52%)

11:28
10/23/18
10/23
11:28
10/23/18
11:28
Hot Stocks
Caterpillar: weak demand for oil, gas drilling equipment »

Caterpillar CFO Andrew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

LMT

Lockheed Martin

$326.11

-0.34 (-0.10%)

11:28
10/23/18
10/23
11:28
10/23/18
11:28
Hot Stocks
Lockheed Martin says business pipeline remains 'robust' »

Says each of four…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 30

    Oct

MCD

McDonald's

$175.92

9.39 (5.64%)

11:26
10/23/18
10/23
11:26
10/23/18
11:26
Hot Stocks
McDonald's sees FY U.S. commodity costs up about 2% »

Sees commodity pressures…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

11:25
10/23/18
10/23
11:25
10/23/18
11:25
Conference/Events
RBC Capital REITs analyst to hold a group luncheon »

REITs Analyst Golladay…

PRTK

Paratek Pharmaceuticals

$8.62

-0.37 (-4.12%)

11:25
10/23/18
10/23
11:25
10/23/18
11:25
Conference/Events
Paratek Pharmaceuticals to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

MCD

McDonald's

$176.28

9.75 (5.85%)

11:22
10/23/18
10/23
11:22
10/23/18
11:22
Hot Stocks
Breaking Hot Stocks news story on McDonald's »

McDonald's: Remodel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HAIN

Hain Celestial

$24.40

-0.39 (-1.57%)

11:20
10/23/18
10/23
11:20
10/23/18
11:20
Options
Bullish option play opened in Hain Celestial as shares fall to 52-week lows »

Bullish option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

NXPI

NXP Semiconductors

$75.90

-0.57 (-0.75%)

, QCOM

Qualcomm

$65.02

-1.06 (-1.60%)

11:20
10/23/18
10/23
11:20
10/23/18
11:20
OnTheFly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

NXPI

NXP Semiconductors

$75.90

-0.57 (-0.75%)

QCOM

Qualcomm

$65.02

-1.06 (-1.60%)

AMD

AMD

$24.52

-0.52 (-2.08%)

INTC

Intel

$44.13

-0.87 (-1.93%)

TSLA

Tesla

$275.89

14.86 (5.69%)

VIA

Viacom

$36.25

-0.36 (-0.98%)

VIAB

Viacom

$32.74

-0.26 (-0.79%)

DISH

Dish

$32.43

-2.23 (-6.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 29

    Oct

  • 01

    Nov

  • 06

    Dec

  • 13

    Dec

NXPI

NXP Semiconductors

$75.89

-0.58 (-0.76%)

, QCOM

Qualcomm

$65.00

-1.08 (-1.63%)

11:19
10/23/18
10/23
11:19
10/23/18
11:19
Hot Stocks
Barclays says buy NXP as recent selling pressure presents opportunity »

In a research note to…

NXPI

NXP Semiconductors

$75.89

-0.58 (-0.76%)

QCOM

Qualcomm

$65.00

-1.08 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

MCD

McDonald's

$176.56

10.03 (6.02%)

, UBER

Uber

$0.00

(0.00%)

11:18
10/23/18
10/23
11:18
10/23/18
11:18
Hot Stocks
Breaking Hot Stocks news story on McDonald's, Uber »

McDonald's sees…

MCD

McDonald's

$176.56

10.03 (6.02%)

UBER

Uber

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
10/23/18
10/23
11:17
10/23/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$176.67

10.14 (6.09%)

, UBER

Uber

$0.00

(0.00%)

11:16
10/23/18
10/23
11:16
10/23/18
11:16
Hot Stocks
Breaking Hot Stocks news story on McDonald's, Uber »

McDonald's says…

MCD

McDonald's

$176.67

10.14 (6.09%)

UBER

Uber

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
10/23/18
10/23
11:16
10/23/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$176.83

10.3 (6.19%)

11:15
10/23/18
10/23
11:15
10/23/18
11:15
Hot Stocks
McDonald's sees 12,000 remodeled restaurants in U.S. by end of 2019 »

Sees "ramping…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

11:15
10/23/18
10/23
11:15
10/23/18
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

11:15
10/23/18
10/23
11:15
10/23/18
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

ERJ

Embraer

$19.65

-0.42 (-2.09%)

11:12
10/23/18
10/23
11:12
10/23/18
11:12
Hot Stocks
Embraer reports ANAC Type Certificate for multi-mission airlift KC-390 »

Embraer announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$117.22

-11.42 (-8.88%)

11:11
10/23/18
10/23
11:11
10/23/18
11:11
Earnings
Caterpillar sees normal seasonal revenue growth in Q4 »

Guidance provided during…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.